Jazz Pharmaceuticals plc buy JPMorgan Chase & Co.
Start price
26.02.25
/
50%
€138.50
Target price
26.02.26
€198.76
Performance (%)
0.72%
Price
13.01.26
€139.50
Summary
This prediction is currently active. The BUY prediction by JPMorgan_Chase___Co_ for Jazz Pharmaceuticals plc is nearly unchanged. This prediction currently runs until 26.02.26. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Jazz Pharmaceuticals plc | -2.413% | -2.413% |
| iShares Core DAX® | 1.644% | 4.865% |
| iShares Nasdaq 100 | 0.747% | 2.923% |
| iShares Nikkei 225® | 2.442% | 6.212% |
| iShares S&P 500 | 0.618% | 2.843% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Jazz Pharmaceuticals plc diskutieren
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) had its price target raised by analysts at JPMorgan Chase & Co. from $200.00 to $209.00. They now have an "overweight" rating on the stock.
Ratings data for JAZZ provided by MarketBeat
Stopped prediction by JPMorgan_Chase___Co_ for Jazz Pharmaceuticals plc
Jazz Pharmaceuticals plc
Start price
Target price
Perf. (%)
€119.45
27.10.25
27.10.25
€171.00
27.10.26
27.10.26
16.79%
13.01.26
13.01.26
Jazz Pharmaceuticals plc
Start price
Target price
Perf. (%)
€102.30
19.08.24
19.08.24
€182.69
19.08.25
19.08.25
-1.37%
20.08.25
20.08.25
Jazz Pharmaceuticals plc
Start price
Target price
Perf. (%)
€112.05
25.03.24
25.03.24
€175.31
25.03.25
25.03.25
11.25%
26.03.25
26.03.25
Jazz Pharmaceuticals plc
Start price
Target price
Perf. (%)
€109.35
29.02.24
29.02.24
€157.28
28.02.25
28.02.25
27.94%
01.03.25
01.03.25